The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "anifrolumab"

Search results for: anifrolumab

New HCPCS Code Added for Anifrolumab-fnia, 1 mg

May 6, 2022 • By From the College

Effective for dates of service on or after April 1, the Healthcare Common Procedure Coding System (HCPCS) code J0491 is valid for billing 1 mg anifrolumab-fnia.... [Read More]

Filed Under: Billing/Coding Tagged With: anifrolumab, Billing & Coding

Anifrolumab Promising for Sustained Low Disease Activity in Patients with Lupus

May 5, 2022 • By Michele B. Kaufman, PharmD, BCGP

ACR CONVERGENCE 2021—Using pooled data from the TULIP-1 and TULIP-2 clinical trials, researchers set out to identify whether more patients with systemic lupus erythematosus (SLE) being treated with anifrolumab achieved a low disease activity state than patients with SLE who received placebo.1-3 An analysis of the data was presented at ACR Convergence 2021 by Eric… [Read More]

Filed Under: ACR Convergence, Drug Updates, Meeting Reports Tagged With: ACR Convergence 2021, anifrolumab, SLE, systemic lupus erythematosus (SLE)

Anifrolumab Promising for SLE

December 13, 2019 • By Michele B. Kaufman, PharmD, BCGP

Recent research has found a higher does of anifrolumab may benefit patients with moderate to severe SLE…... [Read More]

Filed Under: DMARDs & Immunosuppressives, Drug Updates

The Complexity of SLE Drug Research

December 6, 2022 • By Ruth Jessen Hickman, MD

PHILADELPHIA—On Saturday, Nov. 12, at ACR Convergence 2022, Joan T. Merrill, MD, director of clinical projects in the Arthritis & Clinical Immunology Program at the Oklahoma Medical Research Foundation in Oklahoma City, gave a presentation on the future of drug development and treatments for systemic lupus erythematosus (SLE). She described how an in-depth understanding of… [Read More]

Filed Under: ACR Convergence, Conditions, Drug Updates, Meeting Reports, SLE (Lupus) Tagged With: ACR Convergence 2022, Lupus, SLE, SLE Resource Center, Treatment

Updated Perioperative Guideline Released: Recommendations Balance Risks of Infection & Disease Flare

September 13, 2022 • By Ruth Jessen Hickman, MD

The 2017 recommendations are updated to reflect changes in medical literature, as well as to include newly approved drugs. ... [Read More]

Filed Under: Conditions, Guidelines Tagged With: guideline, Perioperative Management of Anti-Rheumatic Medications in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Knee Arthroplasty, total hip arthroplasty, total knee arthroplasty

What’s New in SLE: Pathogenesis & Novel Therapies

September 8, 2022 • By Samantha C. Shapiro, MD

Thomas Dörner, MD, reviewed the current state of systemic lupus erythematosus (SLE) management, providing updates on novel therapies and insights into the pathogenesis of SLE. ... [Read More]

Filed Under: Conditions, Meeting Reports, SLE (Lupus) Tagged With: anifrolumab, belimumab, EULAR 2022, Pathogenesis, SLE, SLE Resource Center, systemic lupus erythematosus (SLE), voclosporin

Dermatologist, Rheumatologist Discuss Refractory Cutaneous Lupus Case

September 5, 2022 • By Richard D. Sontheimer, MD, & Samantha C. Shapiro, MD

As a dermatologist/internist with a career-long subspecialty interest in the cutaneous manifestations of the rheumatic diseases, I found the case of refractory acute cutaneous lupus by Samantha C. Shapiro, MD, in the June 2022 issue of The Rheumatologist intriguing in several ways, and I felt my perspectives on this case might provide additional educational value… [Read More]

Filed Under: Conditions, Opinion, SLE (Lupus) Tagged With: case report, cutaneous lupus erythematosus (CLE), Dermatology, diagnostic imaging, image case, image case report, letter to the editor, SLE Resource Center

An Evidence-Based Drug Update & Guidance for Rheumatologists

August 14, 2022 • By Samantha C. Shapiro, MD

ORLANDO—Despite the COVID-19 pandemic, the past two years have been exciting for rheumatology providers and patients. We’ve seen the U.S. Food & Drug Administration (FDA) approve new therapies and expand indications for established drugs. At the 2022 ACR Education Exchange, Jeffrey Curtis, MD, MS, MPH, Marguerite Jones Harbert-Gene Ball Endowed professor of medicine, Division of… [Read More]

Filed Under: Drug Updates, Education & Training Tagged With: ACR Education Exchange, U.S. Food and Drug Administration (FDA)

Difficult-to-Treat Lupus: When & How to Use New Therapies

July 21, 2022 • By Samantha C. Shapiro, MD

Clinicians have numerous treatment options for SLE; in a EULAR 2022 session, some of the newer therapies were reviewed.... [Read More]

Filed Under: Conditions, Meeting Reports, SLE (Lupus) Tagged With: belimumab, EULAR, EULAR 2022, HCQ, Hydroxychloroquine (HCQ), rituximab, SLE, SLE Resource Center, systemic lupus erythematosus (SLE)

Lupus Update 2021: Classification Criteria, Disease Activity Measures & More

December 2, 2021 • By Jason Liebowitz, MD

An SLE expert discusses the latest SLE stats, classification criteria, disease activity tracking, drugs & more.... [Read More]

Filed Under: ACR Convergence, Conditions, Meeting Reports, SLE (Lupus) Tagged With: ACR Convergence 2021, ACR Convergence 2021 – SLE

  • 1
  • 2
  • 3
  • Next Page »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)